{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:29:57Z","timestamp":1793399397728,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cpcardiol.2024.102538","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:07:12Z","timestamp":1711094832000},"page":"102538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association between psoriasis and atrial fibrillation: A Systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-4299","authenticated-orcid":false,"given":"Hritvik","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez M.","family":"Odat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debankur","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushood","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanpreet Singh","family":"Wasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Passey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey","family":"Gole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2024.102538_bib0001","unstructured":"Nair P.A., Badri T. Psoriasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024 [cited 2024 Mar 8]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448194."},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102538_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0003","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","article-title":"Psoriasis prevalence and severity by expert elicitation","volume":"11","author":"Papp","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","article-title":"Psoriasis: classical and emerging comorbidities","volume":"90","author":"Oliveira","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102538_bib0005","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2008.08707.x","article-title":"Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis","volume":"159","author":"Kaye","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102538_bib0006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2017.03.037","article-title":"Real-world burden of comorbidities in US patients with psoriasis","volume":"77","author":"Shah","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102538_bib0007","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2011.11.025","article-title":"Coronary artery disease in patients with psoriasis referred for coronary angiography","volume":"109","author":"Armstrong","year":"2012","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102538_bib0008","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Investig Dermatol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102538_bib0009","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mcna.2007.09.002","article-title":"Status of the epidemiology of atrial fibrillation","volume":"92","author":"Kannel","year":"2008","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0011","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2015.03.149","article-title":"Psoriasis and risk of atrial fibrillation","volume":"185","author":"Zhang","year":"2015","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/joa3.12473","article-title":"Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge","volume":"37","author":"Nso","year":"2020","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.997698","article-title":"Burden of atrial fibrillation and its attributable risk factors from 1990 to 2019: An analysis of the Global Burden of Disease study 2019","volume":"9","author":"Xu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102538_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102237","article-title":"The impact of chronic total occlusion in non-infarct related arteries on patient outcomes following percutaneous coronary intervention for STEMI superimposed with cardiogenic shock: A pilot systematic review and meta-analysis","volume":"49","author":"Goyal","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0015","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0016","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000683","article-title":"The presence of chronic total occlusion in noninfarct-related arteries is associated with higher mortality and worse patient outcomes following percutaneous coronary intervention for STEMI: a systematic review, meta-analysis and meta-regression","author":"Goyal","year":"2024","journal-title":"Cardiol Rev"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102538_bib0017","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"7414","key":"10.1016\/j.cpcardiol.2024.102538_bib0018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0019","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"issue":"16","key":"10.1016\/j.cpcardiol.2024.102538_bib0020","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study","volume":"33","author":"Ahlehoff","year":"2012","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102538_bib0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00403-013-1419-5","article-title":"Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation","volume":"305","author":"Armstrong","year":"2013","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/HJH.0000000000000078","article-title":"Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint study","volume":"32","author":"Bang","year":"2014","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaad.2015.06.023","article-title":"Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study","volume":"73","author":"Chiu","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102538_bib0024","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bjd.13778","article-title":"Association between depression and risk of atrial fibrillation and stroke in patients with psoriasis: a Danish nationwide cohort study","volume":"173","author":"Egeberg","year":"2015","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102538_bib0025","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/jid.2015.87","article-title":"Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink","volume":"135","author":"Parisi","year":"2015","journal-title":"J Investig Dermatol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0026","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1038\/s41598-017-10556-y","article-title":"Increased risk of atrial fibrillation and thromboembolism in patients with severe psoriasis: a nationwide population-based study","volume":"7","author":"Rhee","year":"2017","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102538_bib0027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/09546634.2016.1255703","article-title":"Psoriasis increases risk of new-onset atrial fibrillation: a systematic review and meta-analysis of prospective observational studies","volume":"28","author":"Upala","year":"2017","journal-title":"J Dermatol Treat"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102538_bib0028","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/0378-6323.186480","article-title":"Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis","volume":"82","author":"Ungprasert","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0029","article-title":"Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102538_bib0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102538_bib0032","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/biomedicines11071825","article-title":"Heart failure and major adverse cardiovascular events in atrial fibrillation patients: a retrospective primary care cohort study","volume":"11","author":"Molt\u00f3-Balado","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0033","doi-asserted-by":"crossref","first-page":"939","DOI":"10.12998\/wjcc.v10.i3.939","article-title":"Atrial fibrillation burden and the risk of stroke: a systematic review and dose-response meta-analysis","volume":"10","author":"Yang","year":"2022","journal-title":"World J Clin Cases"},{"issue":"15","key":"10.1016\/j.cpcardiol.2024.102538_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022555","article-title":"Atrial fibrillation related mortality: another curve to bend","volume":"10","author":"Kanagasundram","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102538_bib0035","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1185\/030079905X65475","article-title":"Economic burden and co-morbidities of atrial fibrillation in a privately insured population","volume":"21","author":"Wu","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102538_bib0036","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0037","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1038\/ncomms7018","article-title":"Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNF\u03b1","volume":"6","author":"Aschar-Sobbi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0038","unstructured":"Elevated levels of interleukin-12\/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes | Cardiovascular Diabetology | Full Text [Internet]. [cited 2024 Mar 11]. Available from: https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01437-w."},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102538_bib0039","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5152\/AnatolJCardiol.2021.69299","article-title":"Prognostic value of interleukin-6 in atrial fibrillation: a cohort study and meta-analysis","volume":"25","author":"Jia","year":"2021","journal-title":"Anatol J Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102538_bib0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/1744666X.2023.2196013","article-title":"The role of interleukins in pathogenesis and prognosis of atrial fibrillation","volume":"19","author":"Lotfi","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0041","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/HJH.0000000000000112","article-title":"Hypertension, inflammation and atrial fibrillation","volume":"32","author":"Angeli","year":"2014","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102538_bib0042","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/biomedicines9111511","article-title":"Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches","volume":"9","author":"Campanati","year":"2021","journal-title":"Biomedicines"},{"issue":"35","key":"10.1016\/j.cpcardiol.2024.102538_bib0043","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/eurheartj\/ehad396","article-title":"Histological validation of atrial structural remodelling in patients with atrial fibrillation","volume":"44","author":"Takahashi","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0044","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1172\/JCI39942","article-title":"Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts","volume":"120","author":"Liao","year":"2010","journal-title":"J Clin Investig"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102538_bib0045","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.hrthm.2013.03.014","article-title":"Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts","volume":"10","author":"Musa","year":"2013","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102538_bib0046","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1002\/ctm2.715","article-title":"Hyperactivation of platelet-derived growth factor signalling contributes to arrhythmogenesis in Brugada syndrome","volume":"12","author":"Wang","year":"2022","journal-title":"Clin Transl Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102538_bib0047","first-page":"1171","article-title":"Role of tumor necrosis factor-\u03b1 in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate","volume":"77","author":"Liew","year":"2013","journal-title":"Circ J Off J Jpn Circ Soc"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102538_bib0048","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1540-8159.2000.tb06761.x","article-title":"Clinical and electrocardiographic predictors of recurrent atrial fibrillation","volume":"23","author":"Dilaveris","year":"2000","journal-title":"Pacing Clin Electrophysiol PACE"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0049","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/03009734.2012.744372","article-title":"Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris","volume":"118","author":"Bacaksiz","year":"2013","journal-title":"Upsala J Med Sci"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000365760","article-title":"Atrial electromechanical delay is impaired in patients with psoriasis","volume":"24","author":"Calapkorur","year":"2015","journal-title":"Med Princ Pract"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102538_bib0051","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/echo.12530","article-title":"Assessment of atrial electromechanical delay and P-wave dispersion in patients with psoriasis","volume":"31","author":"Yildiz","year":"2014","journal-title":"Echocardiography"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102538_bib0052","first-page":"562","article-title":"Psoriasis: recognition and management strategies","volume":"108","author":"Garner","year":"2023","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102538_bib0053","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2796.2012.02593.x","article-title":"Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study","volume":"273","author":"Ahlehoff","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0054","doi-asserted-by":"crossref","DOI":"10.1007\/s40200-023-01332-z","article-title":"Obesity as a risk factor in atrial fibrillation and heart failure","author":"Jurica","year":"2023","journal-title":"J Diabetes Metab Disord"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102538_bib0055","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/nutd.2012.26","article-title":"The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr Diabetes"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102538_bib0056","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102538_bib0057","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520964024","article-title":"Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis","volume":"48","author":"Zhou","year":"2020","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102538_bib0058","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12872-021-02388-6","article-title":"The expression of SAH, IL-1\u03b2, Hcy, TNF-\u03b1 and BDNF in coronary heart disease and its relationship with the severity of coronary stenosis","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpcardiol.2024.102538_bib0059","first-page":"217","article-title":"Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers","volume":"5","author":"Petrescu","year":"2010","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"Suppl 2","key":"10.1016\/j.cpcardiol.2024.102538_bib0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/2047-783X-15-S2-120","article-title":"Proinflammatory cytokines Il-6 and TNF-\u03b1 and the development of inflammation in obese subjects","volume":"15","author":"Popko","year":"2010","journal-title":"Eur J Med Res"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102538_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072884","article-title":"Identifying potential biases in code sequences in primary care electronic healthcare records: a retrospective cohort study of the determinants of code frequency","volume":"13","author":"Beaney","year":"2023","journal-title":"BMJ Open"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624001774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624001774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:38:01Z","timestamp":1714513081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0146280624001774"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102538","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between psoriasis and atrial fibrillation: A Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102538"}}